Adaptive Immune Regulation of Traumatic Injury

创伤性损伤的适应性免疫调节

基本信息

  • 批准号:
    10624318
  • 负责人:
  • 金额:
    $ 41.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-06-10 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Traumatic injuries disrupt immune system homeostasis, which can predispose patients to opportunistic infections and other trauma-associated complications like systemic inflammatory response syndrome (SIRS), organ damage, and chronic critical illnesses. Trauma induces unique and complex host responses that are initiated by tissue damage and the release of danger-associated molecular patterns (DAMPs) that trigger specific immune reactions. We identified that a subset of CD4+ T cells called regulatory T cells (Tregs) are acutely activated by injury in a mouse burn trauma model. The counter-inflammatory suppressive activity of Tregs is enhanced by trauma, which suggests that Tregs may control the intensity of post-trauma inflammation and restoration of immune system homeostasis. People can have different numbers of Tregs in their tissues or have different functional Treg responses to trauma that could determine trajectory of their response to traumatic injuries. Our hypothesis is that Tregs control immune reactions to DAMPs and influence the trajectory of the host response to trauma. To address this hypothesis, we propose a series of trauma immunology studies to systematically interrogate; 1) Treg control of immune system phenotypes and homeostasis, 2) trauma-induced Treg activation mechanisms, and 3) effects of modulating Tregs on immune phenotypes, anti-microbial immune function, and the two-hit SIRS response. The specific aims for this project are; 1) To determine how CD4+ Tregs control immune system reactivity to trauma, 2) To define the specificity and molecular nature of trauma-reactive CD4+ Tregs and other T cells, 3) To investigate how CD4+ Tregs influence anti-microbial immunity and two-hit SIRS. We anticipate that the outcome of this research will significantly advance our fundamental knowledge of specific immune mechanisms that modulate trauma immunity. We have several significant goals that we wish to achieve during the course of this project; 1) to provide new insights into the biology of Treg activation and function, 2) to develop a deeper understanding of immune system control of the mammalian trauma response, and 3) to explore the therapeutic potential of modulating Treg activation and function as a specific trauma immunotherapy to improve immune function and balance following trauma.
项目摘要 创伤性损伤破坏了免疫系统的稳态,这可能使患者容易发生机会性免疫缺陷。 感染和其他创伤相关并发症,如全身炎症反应综合征(SIRS), 器官损伤和慢性危重病。创伤诱导独特而复杂的宿主反应, 由组织损伤和释放引发炎症的炎症相关分子模式(DAMP)引发 特异性免疫反应。我们发现,一个称为调节性T细胞(Treg)的CD 4 + T细胞亚群, 在小鼠烧伤创伤模型中被损伤急性激活。抗炎抑制活性的 创伤可增强TdR,这表明TdR可能控制创伤后炎症的强度 和恢复免疫系统的稳态。人们的组织中可能有不同数量的TbR, 对创伤有不同的功能性Treg反应,这可以决定他们对创伤反应的轨迹, 外伤我们的假设是,TdR控制对DAMP的免疫反应,并影响免疫应答。 宿主对创伤的反应轨迹为了解决这个假设,我们提出了一系列的创伤 免疫学研究以系统地询问; 1)免疫系统表型的Treg控制, 体内平衡,2)创伤诱导的Treg活化机制,和3)调节Treg对免疫调节的作用。 表型、抗微生物免疫功能和两次打击SIRS反应。本项目的具体目标 1)为了确定CD 4 + T细胞如何控制免疫系统对创伤的反应性,2)为了确定CD 4 + T细胞的特异性, 创伤反应性CD 4 + T细胞和其他T细胞的分子性质,3)为了研究CD 4 + T细胞在创伤中的作用, 影响抗微生物免疫和二次感染SIRS。我们预计,这项研究的结果将 显著地推进了我们对调节创伤特异性免疫机制的基础知识 免疫力我们有几个重要的目标,我们希望在这个项目的过程中实现:1) 为Treg激活和功能的生物学提供新的见解,2)更深入地了解 哺乳动物创伤反应的免疫系统控制,以及3)探索 调节Treg活化和功能作为特异性创伤免疫疗法以改善免疫功能, 创伤后的平衡

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Distinct Injury Responsive Regulatory T Cells Identified by Multi-Dimensional Phenotyping.
  • DOI:
    10.3389/fimmu.2022.833100
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    7.3
  • 作者:
  • 通讯作者:
Multiplexed Plasma Immune Mediator Signatures Can Differentiate Sepsis From NonInfective SIRS: American Surgical Association 2020 Annual Meeting Paper.
多路复用血浆免疫介质特征可以将败血症与非感染的SIRS区分开:美国手术协会2020年会议论文。
  • DOI:
    10.1097/sla.0000000000004379
  • 发表时间:
    2020-10
  • 期刊:
  • 影响因子:
    9
  • 作者:
  • 通讯作者:
Trauma induces expansion and activation of a memory-like Treg population.
  • DOI:
    10.1002/jlb.4a0520-122r
  • 发表时间:
    2021-03
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Yamakawa, Kazuma;Tajima, Goro;Keegan, Joshua W.;Nakahori, Yasutaka;Guo, Fei;Seshadri, Anupamaa J.;Cahill, Laura A.;Lederer, James A.
  • 通讯作者:
    Lederer, James A.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES A. LEDERER其他文献

JAMES A. LEDERER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES A. LEDERER', 18)}}的其他基金

Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
针对创伤引起的免疫失调中训练有素的免疫力
  • 批准号:
    10714384
  • 财政年份:
    2023
  • 资助金额:
    $ 41.46万
  • 项目类别:
Adaptive Immune Regulation of Traumatic Injury
创伤性损伤的适应性免疫调节
  • 批准号:
    10415072
  • 财政年份:
    2020
  • 资助金额:
    $ 41.46万
  • 项目类别:
Adaptive Immune Regulation of Traumatic Injury
创伤性损伤的适应性免疫调节
  • 批准号:
    10186694
  • 财政年份:
    2020
  • 资助金额:
    $ 41.46万
  • 项目类别:
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
Toll样受体9激动剂诱导间充质基质细胞治疗急性放射综合征及其并发症
  • 批准号:
    9899920
  • 财政年份:
    2018
  • 资助金额:
    $ 41.46万
  • 项目类别:
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonists
Toll样受体9激动剂诱导间充质基质细胞治疗急性放射综合征及其并发症
  • 批准号:
    10374106
  • 财政年份:
    2018
  • 资助金额:
    $ 41.46万
  • 项目类别:
Cellular Systems Core
蜂窝系统核心
  • 批准号:
    10454989
  • 财政年份:
    2016
  • 资助金额:
    $ 41.46万
  • 项目类别:
Cellular Systems Core
蜂窝系统核心
  • 批准号:
    10281359
  • 财政年份:
    2016
  • 资助金额:
    $ 41.46万
  • 项目类别:
Single Cell and Immunoanalysis Core
单细胞和免疫分析核心
  • 批准号:
    10455094
  • 财政年份:
    2016
  • 资助金额:
    $ 41.46万
  • 项目类别:
Single Cell and Immunoanalysis Core
单细胞和免疫分析核心
  • 批准号:
    10615219
  • 财政年份:
    2016
  • 资助金额:
    $ 41.46万
  • 项目类别:
Cellular Systems Core
蜂窝系统核心
  • 批准号:
    10684886
  • 财政年份:
    2016
  • 资助金额:
    $ 41.46万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.46万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了